19.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$19.53
Aprire:
$19.28
Volume 24 ore:
230.37K
Relative Volume:
1.04
Capitalizzazione di mercato:
$343.10M
Reddito:
$116.88M
Utile/perdita netta:
$-25.09M
Rapporto P/E:
-137.14
EPS:
-0.14
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+1.32%
1M Prestazione:
-1.84%
6M Prestazione:
-30.46%
1 anno Prestazione:
+105.02%
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Nome
Rigel Pharmaceuticals
Settore
Industria
Telefono
650-624-1100
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Confronta RIGL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
RIGL
Rigel Pharmaceuticals
|
19.20 | 338.68M | 116.88M | -25.09M | -20.74M | -0.14 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-04-03 | Ripresa | Piper Sandler | Neutral |
2022-06-09 | Downgrade | Citigroup | Buy → Neutral |
2022-06-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2022-06-08 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-03-23 | Iniziato | B. Riley Securities | Neutral |
2020-11-09 | Downgrade | JP Morgan | Overweight → Neutral |
2019-11-15 | Ripresa | Cantor Fitzgerald | Overweight |
2019-09-26 | Ripresa | JP Morgan | Overweight |
2019-03-01 | Reiterato | Cantor Fitzgerald | Overweight |
2018-08-27 | Iniziato | Citigroup | Buy |
2018-05-02 | Reiterato | Cantor Fitzgerald | Overweight |
2017-12-21 | Ripresa | Piper Jaffray | Overweight |
2017-12-15 | Iniziato | Cantor Fitzgerald | Overweight |
2017-11-06 | Ripresa | H.C. Wainwright | Buy |
2017-03-09 | Reiterato | H.C. Wainwright | Buy |
2016-08-31 | Reiterato | H.C. Wainwright | Buy |
2016-08-30 | Reiterato | Piper Jaffray | Overweight |
2016-07-13 | Iniziato | H.C. Wainwright | Buy |
2016-06-13 | Iniziato | Piper Jaffray | Overweight |
2016-04-22 | Aggiornamento | JP Morgan | Neutral → Overweight |
2013-04-08 | Reiterato | Stifel | Buy |
2012-11-29 | Iniziato | UBS | Neutral |
2012-11-06 | Reiterato | Oppenheimer | Outperform |
2012-03-26 | Iniziato | Canaccord Genuity | Hold |
2010-12-10 | Downgrade | MP Advisors | Outperform → Market Perform |
Mostra tutto
Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference - Kilgore News Herald
Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow
Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow
Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise
Rigel to Present at the Jefferies Global Healthcare Conference | - GuruFocus
(RIGL) Proactive Strategies - news.stocktradersdaily.com
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India
Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire
Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World
(RIGL) Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? - Yahoo Finance
Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet - MSN
Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts - Yahoo Finance
Wells Fargo & Company MN Buys 2,648 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Cantor Fitzgerald Brokers Reduce Earnings Estimates for RIGL - Defense World
B. Riley Expects Reduced Earnings for Rigel Pharmaceuticals - Defense World
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Earnings Estimates Rising for Rigel (RIGL): Will It Gain? - Yahoo Finance
MetLife Investment Management LLC Acquires 2,014 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st
Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance - MSN
Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
HC Wainwright Issues Positive Outlook for RIGL Earnings - Defense World
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of “Hold” by Analysts - Defense World
Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances - TipRanks
Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals (RIGL) Price Target Raised by Cantor Fitzg - GuruFocus
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings - Investing.com Nigeria
Jefferies cuts Rigel stock target to $20.45, maintains hold - Investing.com
Earnings call transcript: Rigel Pharmaceuticals sees stock surge after Q1 2025 earnings By Investing.com - Investing.com South Africa
Rigel Pharma Jump 9.9% Premarket; Guides 'Positive' Net Income in 2025 After Swinging to Profit in Q1 - marketscreener.com
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q1 2025 Earnings Call Highlight - GuruFocus
Rigel Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Rigel: Q1 Earnings Snapshot - CTPost
Rigel Pharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals reports Q1 EPS 63c vs. 47c last year - TipRanks
Rigel Pharmaceuticals reaffirms FY25 revenue $200M-$210M, consensus $197.79M - TipRanks
Rigel Pharmaceuticals (RIGL) Surpasses Q1 Revenue Expectations | - GuruFocus
Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):